These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Back on the scent: the olfactory system in CNS demyelinating diseases. Joseph A; DeLuca GC J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1146-54. PubMed ID: 27003274 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions. Pohl D Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724 [TBL] [Abstract][Full Text] [Related]
8. Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features. Tenembaum SN Neuroimaging Clin N Am; 2017 May; 27(2):229-250. PubMed ID: 28391783 [TBL] [Abstract][Full Text] [Related]
9. [An interpretation of consensus statements on diagnostic criteria for multiple sclerosis and demyelinating diseases of the central nervous system in children (2012 version)]. Yang KF; Chen YC Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1199-1204. PubMed ID: 27974107 [TBL] [Abstract][Full Text] [Related]
10. [Demyelinating diseases in children with acute neurological symptoms]. Olofsson IA; Skov L; Miranda MJ Ugeskr Laeger; 2015 Dec; 177(50):V07150587. PubMed ID: 26651911 [TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions. Ishikawa N; Tajima G; Hyodo S; Takahashi Y; Kobayashi M Neuropediatrics; 2007 Oct; 38(5):257-60. PubMed ID: 18330842 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid analysis in the context of CNS demyelinating diseases. Matas SL; Glehn Fv; Fernandes GB; Soares CA Arq Neuropsiquiatr; 2013 Sep; 71(9B):685-8. PubMed ID: 24141505 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system white matter diseases other than multiple sclerosis. O'Riordan JI Curr Opin Neurol; 1997 Jun; 10(3):211-4. PubMed ID: 9229127 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic criteria of borderline forms of multiple sclerosis]. Dupel-Pottier C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358 [TBL] [Abstract][Full Text] [Related]
16. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Dale RC; Brilot F; Banwell B Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783 [TBL] [Abstract][Full Text] [Related]
17. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Krupp LB; Tardieu M; Amato MP; Banwell B; Chitnis T; Dale RC; Ghezzi A; Hintzen R; Kornberg A; Pohl D; Rostasy K; Tenembaum S; Wassmer E; Mult Scler; 2013 Sep; 19(10):1261-7. PubMed ID: 23572237 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic modalities in multiple sclerosis: perspectives in children. Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory demyelinating diseases in children: an update. Fernández Carbonell C; Chitnis T Minerva Pediatr; 2013 Jun; 65(3):307-23. PubMed ID: 23685382 [TBL] [Abstract][Full Text] [Related]